CD28 ligation increases macrophage suppression of T-cell proliferation

Daniel Silberman1, Amanda Bucknum, Thomas Bartlett

  • 1Department of Biology, Rider University, Lawrenceville, NJ 08648, USA.

Insights

Resident peritoneal cells poorly activate T-cells due to macrophages. Suppressing inducible nitric oxide synthase (iNOS) partially restored T-cell responses, but CD28 ligation further suppressed them by increasing interferon-gamma production.

Area of Science:

  • Immunology
  • Cell Biology

Background:

  • Resident peritoneal cavity cells exhibit poor T-cell activation compared to spleen or lymph node cells.
  • Peritoneal macrophages, prevalent in this cell population, suppress T-cell responses due to an immature phenotype and inducible nitric oxide synthase (iNOS) expression, which catabolizes arginine and promotes T-cell tolerance.

Purpose of the Study:

  • To investigate the efficacy of exogenous T-cell costimulation in restoring the peritoneal T-cell response.
  • To understand the mechanisms underlying the interaction between T-cell costimulation and peritoneal macrophage-mediated suppression.

Main Methods:

  • In vitro T-cell activation assays using peritoneal cells.
  • Inhibition of inducible nitric oxide synthase (iNOS).
  • CD28 ligation for T-cell costimulation.
  • Cytokine ELISpot assays and neutralizing monoclonal antibody (mAb) treatment to assess T-cell responses and cytokine production.

Main Results:

  • CD28 ligation failed to recover the peritoneal T-cell response.
  • CD28 ligation suppressed T-cell responses previously recovered by iNOS inhibition.
  • This suppression, termed 'cosuppression,' was attributed to CD28 ligation increasing the number of interferon-gamma (IFN-γ)-secreting cells.

Conclusions:

  • Cellular composition and the cytokine milieu significantly influence T-cell costimulation biology.
  • Exogenous T-cell costimulation via CD28 ligation can have suppressive effects in the peritoneal environment.
  • Understanding these complex interactions is crucial for modulating immune responses in vivo.